View the latest crypto prices and volume

Quick conversion, zero trading fees, no slippage

Buy and sell crypto with ease

Trade with leverage

Increase your trading volume with our Trading Tournament

USDT Perpetuals

Trade perpetual contracts, settled in USDT

An indicator that reflects the total value of all coins of a certain cryptocurrency on the market

Market Screener

A tool that allows you to filter and track different cryptocurrencies based on multiple criteria

Exchange rates between two currencies expressed through a third currency

Currency Heat map

A visual tool that displays price changes of different cryptocurrencies against each other in the form of a colored map

Technical Analysis

A method for predicting future price movements of cryptocurrencies based on analysis of past market data

Easily stake your coins in PoS by voting and reap rewards

Earn passive income with digital currencies

Buy crypto within seconds via Bank Transfer or Bank Card

Buy crypto using local payment methods

The User Agreement defines the terms of service, user rights, and obligations of both parties.

Policy on combating money laundering, countering the financing of terrorism

The Privacy Policy governs the information collection, use, processing, storage and disclosure practices of the platform

Latest news, updates, and insights from Webyrex

Market analysis, price movements, and trading insights

Platform updates, announcements, and news

Security best practices, tips, and updates

New features, product launches, and improvements

Educational content, guides, and tutorials

Learn more about our payment card

Authentication

Trading

Language

PT - Portuguese

ZH - 繁體中文

Home / Blog / Markets / Toncoin-focused treasury compa...

Markets

Toncoin-focused treasury company AlphaTON agrees to sell cancer treatment subsidiary

February 18, 2026 1 min read 10 views

Toncoin-focused treasury company AlphaTON agrees to sell cancer treatment subsidiary

Share:

Twitter Facebook LinkedIn

Immunova is exercising a call option to acquire iOx Therapeutics Limited, a wholly owned AlphaTON subsidiary that develops cancer treatments.

Related Articles

Onchain lending protocol USD.AI approves $500 million loan for Australian AI startup

Onchain lending protocol USD.AI approves $500 million loan for Australian AI startup

Citi sounds the alarm on ‘address poisoning’ scams flooding the Ethereum network

Citi sounds the alarm on ‘address poisoning’ scams flooding the Ethereum network

Bitwise launches actively managed ETF pairing Bitcoin with gold

Bitwise launches actively managed ETF pairing Bitcoin with gold

BitGo Debuts on NYSE With $18 Shares, $2B Valuation

BitGo Debuts on NYSE With $18 Shares, $2B Valuation

Popular Articles

Fidelity readies digital dollar as stablecoins move into institutional finance

Citi sounds the alarm on ‘address poisoning’ scams flooding the Ethereum network

Trump files $5 billion lawsuit against JPMorgan over 2021 debanking

Tokenized gold boom trims Tether Gold’s market share despite rising XAUT supply

'Obscene': Grammarly's New AI Tool Offers Writing Feedback From Dead Scholars

Latest Articles

CLARITY Act risks handing crypto to centralized players: Gnosis exec

You Can Control an AI Agent's Crypto Spending With Ledger Hardware Wallets and MoonPay

Probe reveals document detailing alleged $5 million deal linking Milei to Libra promotion: report

The SEC and CFTC join hands: State of Crypto

Venus Protocol hit by $3.7M in 'supply cap' attack

Webyrex

Trading

Markets
Swap
Spot
Margin
Futures
Tournament
P2P
Buy Crypto

Support

About Us
Verify Official Channels
Fees
Bug Bounty
Corporate Identity
Institutional Services

Products

Staking
Crypto Lending
Referral Program
Token Listing

Legal & Disclosures

User Agreement
AML Policy
Privacy Policy
Cookies Policy
Risk Disclosure Statement
Special Treatment
Regulatory License
Law Enforcement Requests

© 2026 Webyrex | All rights reserved

💬

Customer Support

Online

We typically reply within minutes. Describe your issue and our team will help you.

Log in to open a support ticket.